Skip to content
healthcare.dev

Pioglitazone

NDC 68071-2264, Pioglitazone, tablet, from NuCare Pharmaceuticals,Inc..

Product NDC
68071-2264
Status
Listed
Labeler
NuCare Pharmaceuticals,Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202467
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2264 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PIOGLITAZONE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator Receptor gamma Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]; Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]; Thiazolidinedione [EPC]; Thiazolidinediones [CS]

Package NDCNDC-11Package
68071-2264-36807122640330 TABLET in 1 BOTTLE (68071-2264-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/af863b9e-9646-3b1e-e053-2995a90ab93a

Use it

Look up 68071-2264 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2264 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68071-2264. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.